RxSight, Inc.
RXST
Rank in Stocks
#16602
As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun... As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.
Share Price
$4.86
Last synced: 2026-11-09
Market Cap
$202.14M
Change (1 day)
7.05%
Change (1 year)
-52.49%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade RxSight, Inc. (RXST)
Category
Healthcare
Operating Margin for RxSight, Inc. (RXST)
Operating Margin as of November 2026 TTM: -43.20%
According to RxSight, Inc.'s latest financial reports, its current operating margin (TTM) is -43.20%. At the end of 2025 the company had an operating margin of -35.84%.
Operating Margin history for RxSight, Inc. from 2019 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -43.20% | 20.54% |
| 2025 | -35.84% | 36.07% |
| 2024 | -26.34% | -53.16% |
| 2023 | -56.23% | -56.48% |
| 2022 | -129.21% | -44.70% |
| 2021 | -233.64% | -3.14% |
| 2020 | -241.21% | -88.27% |
| 2019 | -2,055.78% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -100.35% |
US
|
|
| 18.08% | -100.42% |
IE
|
|
| 21.25% | -100.49% |
US
|
|
| 21.05% | -100.49% |
US
|
|
| 28.09% | -100.65% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about RxSight, Inc.'s operating margin
What is RxSight, Inc.'s operating margin?
RxSight, Inc.'s operating margin is -43.20%, as of Nov 2026.
What was RxSight, Inc.'s operating margin in 2025?
In 2025, RxSight, Inc.'s operating margin was -35.84%, compared with -26.34% in 2024.
How has RxSight, Inc.'s operating margin changed since 2020?
From 2020 to 2025, RxSight, Inc.'s operating margin was highest in 2024 (-26.34%) and lowest in 2020 (-241.21%).
How does RxSight, Inc.'s operating margin compare with similar companies?
RxSight, Inc.'s operating margin (-43.20%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.